Hippocampal metabolite ratios can be used as clinical biomarkers to diagnose Alzheimer’s disease (AD), yet the metabolite ratios at a subfield level have been rarely reported, neither for its clinical diagnostic power. We aim to investigate the diagnostic power of metabolite ratios at a subfield level in AD with comparison to the whole level. A quantitative method of metabolite ratios was used, where 2D 1H-MRSI and 3D T1W volumetric MRI were co-registered. Statistical results show subfields have better diagnostic power than the whole hippocampus through metabolite ratios, and also prove the accuracy of the method for AD diagnosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords